For all intents and purposes, it already is. It is nothing more than a vehicle for employees to get paid. That is why the stock is $.23. And it ain’t getting better.
Insolvent, ZOMBIE Biotech -- just the walking dead. Raising enough cash to keep paying themselves and hope the creditors don't file lawsuits to force BK. No hope of any future as there is no commercially competitive data and now trials outstanding. No MD Anderson -- Kelly never started the study -- just read the SEC filings -- It isn't happening.
News 
Market Data 
Discover 
